Lifestyle
- Regular exercise
- Adequate hydration
- Stress management
Mean Corpuscular Hemoglobin · Mittleres Hämoglobin pro Erythrozyt
MCH measures the average amount of hemoglobin per red blood cell.
Reference ranges may vary slightly by laboratory and population.
Mean Corpuscular Hemoglobin (MCH) is a blood biomarker that quantifies the average amount of hemoglobin per red blood cell. It is calculated by dividing the total hemoglobin by the number of red blood cells, providing insights into the hemoglobin content of individual erythrocytes. Clinically, MCH is significant in diagnosing and monitoring conditions like anemia and thalassemia. Researchers have found that reduced MCH values are indicative of microcytic hypochromic anemia, often seen in iron deficiency and thalassemia carriers. Elevated MCH can be associated with macrocytic anemias, such as those caused by vitamin B12 or folate deficiencies. For athletes and biohackers, MCH can be a marker of oxygen-carrying capacity, potentially affecting endurance and performance. However, it is important to consider confounding factors such as hydration status, recent blood loss, or supplementation, which can affect MCH values. Testing should be consistent in terms of time of day and fasting status to ensure comparability.
Klinische Bedeutung
Reduced MCH values often indicate microcytic anemia, such as iron deficiency or thalassemia. Elevated MCH values may suggest macrocytic anemia, often due to vitamin B12 or folate deficiency.
Progressively rising MCH values may indicate developing macrocytic anemia. Re-test in 4 weeks if outside the optimal range.
Progressively falling MCH values suggest worsening microcytic anemia, potentially due to iron deficiency.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a physician before supplementing iron or vitamin B12, especially if underlying conditions are suspected.
Testing Frequency
Annually for healthy adults, more frequently if managing anemia.
May affect
Current research suggests that reference ranges for mean corpuscular hemoglobin (MCH) in specific populations, particularly in relation to thalassemia carriers, remain debated, with optimal targets not yet established. Emerging research directions include the integration of MCH with other hematological indices to improve diagnostic algorithms for hemoglobinopathies. Additionally, clinical questions remain unanswered regarding the impact of confounding factors, such as iron status and inflammation, on MCH levels and their interpretation in diverse patient populations.
828
Total Citations
25
Human/RCT
2.2
Avg. Influence
2025
Latest
This study examined the laboratory diagnosis of thalassemia, highlighting the importance of hematological tests in identifying carriers. Researchers found that mean corpuscular hemoglobin (MCH) levels are significantly reduced in β-thalassemia carriers, with values ranging from 19-23 pg. The study also emphasized the role of HbA2 determination in detecting β-carriers and the necessity of molecular analysis for confirming α-thalassemia carrier status.
Researchers explored the role of kisspeptins in linking energy balance and reproduction. The study highlighted that metabolic modulators, including melanin-concentrating hormone (MCH), may influence kisspeptin signaling and thus reproductive functions. This research underscores the complex interactions between metabolic state and reproductive health.
This study focused on the laboratory diagnosis of hemoglobinopathies, emphasizing the significance of MCH in screening for beta-thalassemia trait. Researchers found that testing should be considered when MCH is below 27 pg, highlighting the importance of specific laboratory tests in genetic counseling and antenatal diagnosis.
This comparative study analyzed the morphology of the melanin-concentrating hormone (MCH) system in different rodent species. Researchers observed distinct anatomical features of MCH neurons, suggesting evolutionary adaptations in the MCH system across species. The findings contribute to understanding the functional roles of MCH in vertebrates.
Researchers established new hematology and clinical chemistry reference ranges for adults in Zimbabwe. They found significant differences in mean corpuscular hemoglobin (MCH) levels between genders, indicating the need for updated reference values for accurate clinical care.
Researchers discussed the impact of lipemia on clinical laboratory results, noting that mean corpuscular hemoglobin (MCHC) concentration can be affected. They emphasized the need for standardized protocols to handle lipemic samples to ensure accurate measurement of biological quantities.
Researchers investigated the association between mean corpuscular hemoglobin concentration (MCHC) and prognosis in patients with COPD exacerbation. The study found that lower MCHC was linked to higher 30-day mortality rates, suggesting it may serve as a valuable prognostic biomarker.
This study established age- and sex-specific reference intervals for hematologic parameters in children and adolescents. Researchers found that most parameters, including MCH, showed significant variations during growth, necessitating pediatric-specific reference standards for accurate test interpretation.
Research publications about MCH over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer